Literature DB >> 9841587

Update in pulmonary medicine.

T E King1.   

Abstract

Mesh：

Year:  1998        PMID： 9841587     DOI： 10.7326/0003-4819-129-10-199811150-00012

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  9 in total

1.  Global analysis of gene expression in pulmonary fibrosis reveals distinct programs regulating lung inflammation and fibrosis.

Authors:  N Kaminski; J D Allard; J F Pittet; F Zuo; M J Griffiths; D Morris; X Huang; D Sheppard; R A Heller
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-15       Impact factor: 11.205

2.  Lysophosphatidic acid receptor-2 deficiency confers protection against bleomycin-induced lung injury and fibrosis in mice.

Authors:  Long Shuang Huang; Panfeng Fu; Priya Patel; Anantha Harijith; Tianjiao Sun; Yutong Zhao; Joe G N Garcia; Jerold Chun; Viswanathan Natarajan
Journal:  Am J Respir Cell Mol Biol       Date:  2013-12       Impact factor: 6.914

3.  Gene expression analysis reveals matrilysin as a key regulator of pulmonary fibrosis in mice and humans.

Authors:  Fengrong Zuo; Naftali Kaminski; Elsie Eugui; John Allard; Zohar Yakhini; Amir Ben-Dor; Lance Lollini; David Morris; Yong Kim; Barbara DeLustro; Dean Sheppard; Annie Pardo; Moises Selman; Renu A Heller
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-30       Impact factor: 11.205

Review 4.  Sphingolipids in pulmonary fibrosis.

Authors:  Long Shuang Huang; Viswanathan Natarajan
Journal:  Adv Biol Regul       Date:  2014-10-13

5.  The mitochondrial cardiolipin remodeling enzyme lysocardiolipin acyltransferase is a novel target in pulmonary fibrosis.

Authors:  Long Shuang Huang; Biji Mathew; Haiquan Li; Yutong Zhao; Shwu-Fan Ma; Imre Noth; Sekhar P Reddy; Anantha Harijith; Peter V Usatyuk; Evgeny V Berdyshev; Naftali Kaminski; Tong Zhou; Wei Zhang; Yanmin Zhang; Jalees Rehman; Sainath R Kotha; Travis O Gurney; Narasimham L Parinandi; Yves A Lussier; Joe G N Garcia; Viswanathan Natarajan
Journal:  Am J Respir Crit Care Med       Date:  2014-06-01       Impact factor: 21.405

6.  Overexpression of alpha1-protease inhibitor and galectin-1 in radiation-induced early phase of pulmonary fibrosis.

Authors:  Hee-Soon Im; Hyung-Doo Kim; Jie-Young Song; Youngsoo Han; Do-Youn Lee; Chan-Wha Kim; Yeon-Sook Yun
Journal:  Cancer Res Treat       Date:  2006-04-30       Impact factor: 4.679

7.  Targeting sphingosine kinase 1 attenuates bleomycin-induced pulmonary fibrosis.

Authors:  Long Shuang Huang; Evgeny Berdyshev; Biji Mathew; Panfeng Fu; Irina A Gorshkova; Donghong He; Wenli Ma; Imre Noth; Shwu-Fan Ma; Srikanth Pendyala; Sekhar P Reddy; Tong Zhou; Wei Zhang; Steven A Garzon; Joe G N Garcia; Viswanathan Natarajan
Journal:  FASEB J       Date:  2013-01-11       Impact factor: 5.191

8.  Transforming growth factor β regulates β-catenin expression in lung fibroblast through NF-κB dependent pathway.

Authors:  Jian Li; Gang Wang; Xia Sun
Journal:  Int J Mol Med       Date:  2014-08-27       Impact factor: 4.101

9.  Sphingosine Kinase 1/S1P Signaling Contributes to Pulmonary Fibrosis by Activating Hippo/YAP Pathway and Mitochondrial Reactive Oxygen Species in Lung Fibroblasts.

Authors:  Long Shuang Huang; Tara Sudhadevi; Panfeng Fu; Prasanth-Kumar Punathil-Kannan; David Lenin Ebenezer; Ramaswamy Ramchandran; Vijay Putherickal; Paul Cheresh; Guofei Zhou; Alison W Ha; Anantha Harijith; David W Kamp; Viswanathan Natarajan
Journal:  Int J Mol Sci       Date:  2020-03-17       Impact factor: 5.923
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.